Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Registry (Prospective Cohort) for Heart Failure in Korea (KorAHF) (KorAHF)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute of Health, Korea
Information provided by (Responsible Party):
Byung-Hee Oh, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01389843
First received: July 6, 2011
Last updated: April 18, 2016
Last verified: April 2016
  Purpose

KorAHF is a multi-center registry (prospective cohort) for acute decompensated heart failure patients in Korea.

The aim of this registry is to analyze several causes affecting prognosis and survival and to develop new strategies for managing acute decompensated heart failure.


Condition
Acute Decompensated Heart Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Registry (Prospective Cohort) for Heart Failure in Korea (KorAHF)

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Mortality and Re-hospitalization of acute decompensated heart failure [ Time Frame: 5 years (tentative) ] [ Designated as safety issue: No ]
    1. In-hospital mortality
    2. Annual mortality
    3. Re-hospitalization


Enrollment: 5625
Study Start Date: March 2011
Estimated Study Completion Date: December 2018
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts
All consecutive hospitalized adult patients

All consecutive hospitalized adult patients who have 1 and (2 and/or 3)

  1. Symptom and/or sign of heart failure
  2. Lung congestion
  3. Objective finding of LV systolic dysfunction (LVEF), or structural heart disease.

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
acute decompensated heart failure
Criteria

Inclusion Criteria:

All consecutive hospitalized adult patients who have 1 and (2 and/or 3)

  1. Symptom and/or sign of heart failure
  2. Lung congestion
  3. Objective finding of LV systolic dysfunction (LVEF), or structural heart disease

Exclusion Criteria:

  • N.C.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01389843

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 03080
Sponsors and Collaborators
Byung-Hee Oh
National Institute of Health, Korea
Investigators
Principal Investigator: Byung-Hee Oh, MD, PhD Seoul National University Hospital
  More Information

Responsible Party: Byung-Hee Oh, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01389843     History of Changes
Other Study ID Numbers: H-1102-072-352 
Study First Received: July 6, 2011
Last Updated: April 18, 2016
Health Authority: Korea: Ministry for Health and Welfare
Individual Participant Data  
Plan to Share IPD: Yes
Plan Description: Data be shared with participating institution and NNIH

Keywords provided by Seoul National University Hospital:
Heart failure
Registry
Cohort
Heart Disease
Cardiovascular Diseases

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 23, 2016